- Synchronous Occurrence of Bilateral Malignant Otitis Externa: Report of a Rare Case
-
Lamry NA, Misron K, Tengku Kamalden TMI, Aziz A, Salim R
- KMID: 2522864
- Korean J Fam Med.
- 2021 Nov;42(6):483-486.
- doi: 10.4082/kjfm.20.0071
Malignant otitis externa (MOE) is a rare and potentially life-threatening disease of the ear and temporal bone. Bilateral simultaneous MOE is extremely rare. Due to bilaterally symmetrical facial nerve palsy,... -
- CITED
-
- Close
- SHARE
-
- Close
- Simultaneous Surgical Treatment of Vestibular Schwannoma and Hemifacial Spasm via Minimally Invasive Retrosigmoid Approach
-
Misron K, Mfuko G, Lee JG, Moon IS
- KMID: 2530289
- Korean J Otorhinolaryngol-Head Neck Surg.
- 2022 May;65(5):296-299.
- doi: 10.3342/kjorl-hns.2021.00332
The combination of vestibular schwannoma (VS) and hemifacial spasm (HFS) caused by a vascular loop is not frequently encountered. Surgical intervention using the retrosigmoid approach may enable the two diseases... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinico-Radiological Manifestations of Cochlear Schwannomas
-
Hashim ND, Misron K, Moon SJ, Noh HE, Kim J, Moon IS
- KMID: 2560176
- J Audiol Otol.
- 2024 Oct;28(4):284-290.
- doi: 10.7874/jao.2024.00115
Background and Objectives: Cochlear schwannomas, which are categorized into intracochlear and intravestibulocochlear schwannomas (ICs and IVCs, respectively) are rare and may cause hearing loss (HL). The affected region is invariably... -
- CITED
-
- Close
- SHARE
-
- Close
- A Study of Single Nucleotide Polymorphisms of Tumour Necrosis Factor α-1031 And Tumour Necrosis Factor β+ 252 in Chronic Rhinosinusitis
-
Misron K, Hamid SS, Ahmad A, Ramli RR
- KMID: 2395738
- Clin Exp Otorhinolaryngol.
- 2017 Sep;10(3):241-247.
- doi: 10.21053/ceo.2016.01732
OBJECTIVES: This case-controlled study aimed to identify the association of tumor necrosis factor (TNF)α-1031 and TNFβ+ 252 gene polymorphisms between chronic rhinosinusitis (CRS) and healthy controls. Another purpose of this... -
- CITED
-
- Close
- SHARE
-
- Close
